Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 69
Filter
1.
Parasit Vectors ; 12(1): 262, 2019 May 24.
Article in English | MEDLINE | ID: mdl-31126349

ABSTRACT

BACKGROUND: Chagas disease is a potentially life-threatening disease caused by the protozoan parasite Trypanosoma cruzi. Current therapeutic management is limited to treatment with nitroheterocyclic drugs, such as nifurtimox (NFX) and benznidazole (BZ). Thus, the identification of affordable and readily available drugs to treat resistant parasites is urgently required worldwide. To analyse the effects of BZ on human macrophage gene expression, a quantitative PCR (qPCR) array analysis was performed using drug transporter and oxidative stress pathway genes to compare the gene expression profiles of human differentiated THP-1 macrophage (THP-1 MΦ) cells infected or not with benznidazole-sensitive (CL Brener) and naturally benznidazole-resistant (Colombiana) T. cruzi parasites followed by treatment with BZ. RESULTS: The gene expression analysis indicated that the expression levels of 62 genes were either up- or downregulated at least 3-fold in the host upon infection with CL Brener and BZ treatment, of which 46 were upregulated and 16 were downregulated. Moreover, the expression level of 32 genes was altered in THP-1 MФ cells infected with Colombiana and treated with BZ, of which 29 were upregulated and 3 were downregulated. Our results revealed that depending on the specific condition, human THP-1 MΦ cells infected with T. cruzi strains with sensitive or resistant phenotypes and treated with BZ expressed high mRNA levels of AQP1, AQP9 and ABCB1 (MDR1) compared to those of the control cells. CONCLUSIONS: Our findings suggest that the proteins encoded by AQP1, AQP9 and ABCB1 may be implicated in benznidazole detoxification. Therefore, studies on gene expression are required to better understand the host response to pathogens and drug treatment integrated with functional and metabolic data to identify potentially novel targets for the treatment of this important and neglected tropical disease.


Subject(s)
Drug Resistance , Macrophages/drug effects , Macrophages/parasitology , Nitroimidazoles/pharmacology , Oxidative Stress , Trypanosoma cruzi/drug effects , DNA, Protozoan/genetics , Gene Expression , Humans , Phylogeny , Real-Time Polymerase Chain Reaction , THP-1 Cells
2.
Mem Inst Oswaldo Cruz ; 113(9): e180162, 2018 Jul 26.
Article in English | MEDLINE | ID: mdl-30066751

ABSTRACT

Eukaryotic initiation factor 5A (eIF5A) is a conserved protein with an essential role in translation elongation. Using one and two-dimensional western blotting, we showed that the eIF5A protein level was 2-fold lower in benznidazole (BZ)-resistant (BZR and 17LER) Trypanosoma cruzi populations than in their respective susceptible counterparts (BZS and 17WTS). To confirm the role of eIF5A in BZ resistance, we transfected BZS and 17WTS with the wild-type eIF5A or mutant eIF5A-S2A (in which serine 2 was replaced by alanine). Upon overexpressing eIF5A, both susceptible lines became approximately 3- and 5-fold more sensitive to BZ. In contrast, the eIF5A-S2A mutant did not alter its susceptibility to BZ. These data suggest that BZ resistance might arise from either decreasing the translation of proteins that require eIF5A, or as a consequence of differential levels of precursors for the hypusination reactions (e.g., spermidine and trypanothione), both of which alter BZ's effects in the parasite.


Subject(s)
Drug Resistance/genetics , Nitroimidazoles/pharmacology , Peptide Initiation Factors/metabolism , RNA-Binding Proteins/metabolism , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Trypanosoma cruzi/enzymology , Gene Expression , Humans , Peptide Initiation Factors/analysis , Peptide Initiation Factors/drug effects , RNA-Binding Proteins/analysis , RNA-Binding Proteins/drug effects , Trypanosoma cruzi/genetics , Eukaryotic Translation Initiation Factor 5A
3.
Mem. Inst. Oswaldo Cruz ; 113(9): e180162, 2018. graf
Article in English | LILACS | ID: biblio-1040603

ABSTRACT

Eukaryotic initiation factor 5A (eIF5A) is a conserved protein with an essential role in translation elongation. Using one and two-dimensional western blotting, we showed that the eIF5A protein level was 2-fold lower in benznidazole (BZ)-resistant (BZR and 17LER) Trypanosoma cruzi populations than in their respective susceptible counterparts (BZS and 17WTS). To confirm the role of eIF5A in BZ resistance, we transfected BZS and 17WTS with the wild-type eIF5A or mutant eIF5A-S2A (in which serine 2 was replaced by alanine). Upon overexpressing eIF5A, both susceptible lines became approximately 3- and 5-fold more sensitive to BZ. In contrast, the eIF5A-S2A mutant did not alter its susceptibility to BZ. These data suggest that BZ resistance might arise from either decreasing the translation of proteins that require eIF5A, or as a consequence of differential levels of precursors for the hypusination reactions (e.g., spermidine and trypanothione), both of which alter BZ's effects in the parasite.


Subject(s)
Humans , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Trypanosoma cruzi/enzymology , Drug Resistance/genetics , Peptide Initiation Factors/metabolism , RNA-Binding Proteins/metabolism , Nitroimidazoles/pharmacology , Trypanosoma cruzi/genetics , Gene Expression , Peptide Initiation Factors/analysis , Peptide Initiation Factors/drug effects , RNA-Binding Proteins/analysis , RNA-Binding Proteins/drug effects
4.
Article in English | MEDLINE | ID: mdl-28461312

ABSTRACT

Leishmaniasis is a neglected tropical disease that affects millions of people worldwide and represents a major public health problem. Information on protein expression patterns and functional roles within the context of Leishmania-infected human monocyte-derived macrophages (MDMs) under drug treatment conditions is essential for understanding the role of these cells in leishmaniasis treatment. We analyzed functional changes in the expression of human MDM genes and proteins during in vitro infection by Leishmania braziliensis and treatment with Glucantime (SbV), using quantitative PCR (qPCR) arrays, Western blotting, confocal microscopy, and small interfering RNA (siRNA) human gene inhibition assays. Comparison of the results from gene transcription and protein expression analyses revealed that glutathione S-transferase π1 (GSTP1), glutamate-cysteine ligase modifier subunit (GCLM), glutathione reductase (GSR), glutathione synthetase (GSS), thioredoxin (TRX), and ATP-binding cassette, subfamily B, member 5 (ABCB5), were strongly upregulated at both the mRNA and protein levels in human MDMs that were infected and treated, compared to the control group. Subcellular localization studies showed a primarily phagolysosomal location for the ABCB5 transporter, indicating that this protein may be involved in the transport of SbV By inducing a decrease in L. braziliensis intracellular survival in THP-1 macrophages, siRNA silencing of GSTP1, GSS, and ABCB5 resulted in an increased leishmanicidal effect of SbV exposure in vitro Our results suggest that human MDMs infected with L. braziliensis and treated with SbV express increased levels of genes participating in antioxidant defense, whereas our functional analyses provide evidence for the involvement of human MDMs in drug detoxification. Therefore, we conclude that GSS, GSTP1, and ABCB5 proteins represent potential targets for enhancing the leishmanicidal activity of Glucantime.


Subject(s)
Leishmania braziliensis/drug effects , Leishmania braziliensis/pathogenicity , Macrophages/drug effects , Macrophages/metabolism , Meglumine/pharmacology , Organometallic Compounds/pharmacology , ATP Binding Cassette Transporter, Subfamily B , ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Antioxidants/metabolism , Glutamate-Cysteine Ligase/metabolism , Glutathione Reductase/metabolism , Glutathione S-Transferase pi/metabolism , Glutathione Synthase/metabolism , Host-Pathogen Interactions , Humans , Meglumine Antimoniate , Polymerase Chain Reaction
5.
Bioorg Med Chem ; 25(6): 1889-1900, 2017 03 15.
Article in English | MEDLINE | ID: mdl-28215783

ABSTRACT

Analogues of 8-chloro-N-(3-morpholinopropyl)-5H-pyrimido[5,4-b]indol-4-amine 1, a known cruzain inhibitor, were synthesized using a molecular simplification strategy. Five series of analogues were obtained: indole, pyrimidine, quinoline, aniline and pyrrole derivatives. The activity of the compounds was evaluated against the enzymes cruzain and rhodesain as well as against Trypanosoma cruzi amastigote and trypomastigote forms. The 4-aminoquinoline derivatives showed promising activity against both enzymes, with IC50 values ranging from 15 to 125µM. These derivatives were selective inhibitors for the parasitic proteases, being unable to inhibit mammalian cathepsins B and S. The most active compound against cruzain (compound 5a; IC50=15µM) is considerably more synthetically accessible than 1, while retaining its ligand efficiency. As observed for the original lead, compound 5a was shown to be a competitive enzyme inhibitor. In addition, it was also active against T. cruzi (IC50=67.7µM). Interestingly, the pyrimidine derivative 4b, although inactive in enzymatic assays, was highly active against T. cruzi (IC50=3.1µM) with remarkable selectivity index (SI=128) compared to uninfected fibroblasts. Both 5a and 4b exhibit drug-like physicochemical properties and are predicted to have a favorable ADME profile, therefore having great potential as candidates for lead optimization in the search for new drugs to treat Chagas disease.


Subject(s)
Cysteine Endopeptidases/drug effects , Cysteine Proteinase Inhibitors/chemical synthesis , Cysteine Proteinase Inhibitors/pharmacology , Protozoan Proteins/antagonists & inhibitors , Cysteine Proteinase Inhibitors/chemistry , Drug Evaluation, Preclinical , Spectrum Analysis/methods , Trypanosoma cruzi/drug effects , Trypanosoma cruzi/enzymology
6.
Molecules ; 21(10)2016 Oct 10.
Article in English | MEDLINE | ID: mdl-27735872

ABSTRACT

A series of novel xylitan derivatives derived from xylitol were synthesized using operationally simple procedures. A xylitan acetonide was the key intermediate used to prepare benzoate, arylsulfonate esters and 1,2,3-triazole derivatives of xylitan. These compounds were evaluated for their in vitro anti-Trypanosoma cruzi activity against trypomastigote and amastigote forms of the parasite in T. cruzi-infected cell lineages. Benznidazole was used as positive control against T. cruzi and cytotoxicity was determined in mammalian L929 cells. The arylsulfonate xylitan derivative bearing a nitro group displayed the best activity of all the compounds tested, and was slightly more potent than the reference drug benznidazole. The importance of the isopropylidene ketal moiety was established and the greater lipophilicity of these compounds suggests enhancement in cell penetration.


Subject(s)
Trypanocidal Agents/chemical synthesis , Trypanocidal Agents/pharmacology , Xylitol/chemical synthesis , Xylitol/pharmacology , Humans , Parasitic Sensitivity Tests , Trypanosoma cruzi/drug effects , Xylitol/analogs & derivatives
7.
Asian Pac J Trop Med ; 9(8): 735-41, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27569881

ABSTRACT

OBJECTIVE: To evaluate the in vitro anti-Trypanosoma cruzi (T. cruzi) activity of organic extracts prepared from halophyte species collected in the southern coast of Portugal (Algarve), and chemically characterize the most active samples. METHODS: Acetone, dichloromethane and methanol extracts were prepared from 31 halophyte species and tested in vitro against trypomastigotes and intracellular amastigotes of the Tulahuen strain of T. cruzi. The most active extract was fractionated by preparative HPLC-DAD, affording 11 fractions. The most selective fraction was fully characterized by (1)H NMR. RESULTS: From 94 samples tested, one was active, namely the root dichloromethane extract of Juncus acutus (IC50 < 20 µg/mL). This extract was fractionated by HPLC, affording 11 fractions, one of them containing only a pure compound (juncunol), and tested for anti-parasitic activity. Fraction 8 (IC50 = 4.1 µg/mL) was the most active, and was further characterized by (1)H NMR. The major compounds were phenanthrenes, 9,10-dihydrophenanthrenes and benzocoumarins. CONCLUSION: Our results suggest that the compounds identified in fraction 8 are likely responsible for the observed anti parasitic activity. Further research is in progress aiming to isolate and identify the specific active molecules. To the best of our knowledge, this is the first report on the in vitro anti T. cruzi activity of halophyte species.

8.
Eur J Med Chem ; 101: 818-35, 2015 Aug 28.
Article in English | MEDLINE | ID: mdl-26231082

ABSTRACT

The discovery of new antiparasitic compounds against Trypanosoma cruzi, the etiological agent of Chagas disease, is necessary. Novel aryloxy/aryl thiosemicarbazone-based conformationally constrained analogs of thiosemicarbazones (1) and (2) were developed as potential inhibitors of the T. cruzi protease cruzain, using a rigidification strategy of the iminic bond of (1) and (2). A structure-activity relationship analysis was performed in substituents attached in both aryl and aryloxy rings. This study indicated that apolar substituents or halogen atom substitution at the aryl position improved cruzain inhibition and antiparasitic activity in comparison to unsubstituted thiosemicarbazone. Two of these compounds displayed potent inhibitory antiparasitic activity by inhibiting cruzain and consequently were able to reduce the parasite burden in infected cells and cause parasite cell death through necrosis. In conclusion, we demonstrated that conformational restriction is a valuable strategy in the development of antiparasitic thiosemicarbazones.


Subject(s)
Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/pharmacology , Protozoan Proteins/antagonists & inhibitors , Thiosemicarbazones/pharmacology , Trypanocidal Agents/chemistry , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Crystallography, X-Ray , Cysteine Endopeptidases/metabolism , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemistry , Models, Molecular , Molecular Structure , Parasitic Sensitivity Tests , Protozoan Proteins/metabolism , Structure-Activity Relationship , Thiosemicarbazones/chemical synthesis , Thiosemicarbazones/chemistry , Trypanocidal Agents/chemical synthesis , Trypanosoma cruzi/enzymology
9.
Mem Inst Oswaldo Cruz ; 110(4): 566-8, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26061148

ABSTRACT

We describe herein the antitrypanosomal activity of 20 novel 1,3-bis(aryloxy)propan-2-amine derivatives. Compounds 2, 4, 6, 12, 15, 16 and 19 were significantly active against amastigote and trypomastigote forms, with half maximal inhibitory concentrationvalues in the range of 6-18 µM. In the cytotoxicity tests against L929 cells, only compound 4 presented selectivity index value above 10, indicating low toxicity.


Subject(s)
Benzene Derivatives/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Cell Line , Inhibitory Concentration 50 , Parasitic Sensitivity Tests
10.
Antimicrob Agents Chemother ; 59(8): 4770-81, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26033728

ABSTRACT

Cysteine metabolism is considered essential for the crucial maintenance of a reducing environment in trypanosomatids due to its importance as a precursor of trypanothione biosynthesis. Expression, activity, functional rescue, and overexpression of cysteine synthase (CS) and cystathionine ß-synthase (CßS) were evaluated in Leishmania braziliensis promastigotes and intracellular amastigotes under in vitro stress conditions induced by hydrogen peroxide (H2O2), S-nitroso-N-acetylpenicillamine, or antimonial compounds. Our results demonstrate a stage-specific increase in the levels of protein expression and activity of L. braziliensis CS (LbrCS) and L. braziliensis CßS (LbrCßS), resulting in an increment of total thiol levels in response to both oxidative and nitrosative stress. The rescue of the CS activity in Trypanosoma rangeli, a trypanosome that does not perform cysteine biosynthesis de novo, resulted in increased rates of survival of epimastigotes expressing the LbrCS under stress conditions compared to those of wild-type parasites. We also found that the ability of L. braziliensis promastigotes and amastigotes overexpressing LbrCS and LbrCßS to resist oxidative stress was significantly enhanced compared to that of nontransfected cells, resulting in a phenotype far more resistant to treatment with the pentavalent form of Sb in vitro. In conclusion, the upregulation of protein expression and increment of the levels of LbrCS and LbrCßS activity alter parasite resistance to antimonials and may influence the efficacy of antimony treatment of New World leishmaniasis.


Subject(s)
Cystathionine beta-Synthase/genetics , Cysteine Synthase/genetics , Leishmania braziliensis/genetics , Oxidative Stress/physiology , Protozoan Proteins/genetics , Up-Regulation/genetics , Antimony/pharmacology , Antiprotozoal Agents/pharmacology , Cell Line , Humans , Hydrogen Peroxide/pharmacology , Leishmania braziliensis/drug effects , Leishmaniasis, Cutaneous/drug therapy , Leishmaniasis, Cutaneous/parasitology , Oxidative Stress/drug effects , Transcriptional Activation/drug effects , Transcriptional Activation/genetics , Trypanosoma rangeli/drug effects , Trypanosoma rangeli/genetics , Up-Regulation/drug effects
11.
Mem Inst Oswaldo Cruz ; 110(1): 65-74, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25742265

ABSTRACT

Aiming to identify new sources of bioactive secondary metabolites, we isolated 82 endophytic fungi from stems and barks of the native Brazilian tree Caesalpinia echinata Lam. (Fabaceae). We tested their ethyl acetate extracts in several in vitro assays. The organic extracts from three isolates showed antibacterial activity against Staphylococcus aureus and Escherichia coli [minimal inhibitory concentration (MIC) 32-64 µg/mL]. One isolate inhibited the growth of Salmonella typhimurium (MIC 64 µg/mL) and two isolates inhibited the growth of Klebsiella oxytoca (MIC 64 µg/mL), Candida albicans and Candida tropicalis (MIC 64-128 µg/mL). Fourteen extracts at a concentration of 20 µg/mL showed antitumour activities against human breast cancer and human renal cancer cells, while two isolates showed anti-tumour activities against human melanoma cancer cells. Six extracts were able to reduce the proliferation of human peripheral blood mononuclear cells, indicating some degree of selective toxicity. Four isolates were able to inhibit Leishmania (Leishmania) amazonensis and one isolate inhibited Trypanosoma cruzi by at least 40% at 20 µg/mL. The trypanocidal extract obtained from Fusarium sp. [KF611679] culture was subjected to bioguided fractionation, which revealed beauvericin as the compound responsible for the observed toxicity of Fusarium sp. to T. cruzi. This depsipeptide showed a half maximal inhibitory concentration of 1.9 µg/mL (2.43 µM) in a T. cruzi cellular culture assay.


Subject(s)
Caesalpinia/microbiology , Depsipeptides/pharmacology , Endophytes/isolation & purification , Fusarium/isolation & purification , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Anti-Infective Agents/isolation & purification , Anti-Infective Agents/pharmacology , Candida albicans/drug effects , Cell Line, Tumor/drug effects , Chemical Fractionation , Complex Mixtures , DNA Primers , Depsipeptides/isolation & purification , Endophytes/classification , Enterobacteriaceae/drug effects , Fusarium/metabolism , Gram-Positive Endospore-Forming Rods/drug effects , Humans , Leishmania/drug effects , Leukocytes, Mononuclear/drug effects , Microbial Sensitivity Tests , Pseudomonas aeruginosa/drug effects , Trypanocidal Agents/isolation & purification
12.
Antimicrob Agents Chemother ; 59(5): 2666-77, 2015 May.
Article in English | MEDLINE | ID: mdl-25712353

ABSTRACT

The pressing need for better drugs against Chagas disease, African sleeping sickness, and schistosomiasis motivates the search for inhibitors of cruzain, rhodesain, and Schistosoma mansoni CB1 (SmCB1), the major cysteine proteases from Trypanosoma cruzi, Trypanosoma brucei, and S. mansoni, respectively. Thiosemicarbazones and heterocyclic analogues have been shown to be both antitrypanocidal and inhibitory against parasite cysteine proteases. A series of compounds was synthesized and evaluated against cruzain, rhodesain, and SmCB1 through biochemical assays to determine their potency and structure-activity relationships (SAR). This approach led to the discovery of 6 rhodesain, 4 cruzain, and 5 SmCB1 inhibitors with 50% inhibitory concentrations (IC50s) of ≤ 10 µM. Among the compounds tested, the thiosemicarbazone derivative of peracetylated galactoside (compound 4i) was discovered to be a potent rhodesain inhibitor (IC50 = 1.2 ± 1.0 µM). The impact of a range of modifications was determined; removal of thiosemicarbazone or its replacement by semicarbazone resulted in virtually inactive compounds, and modifications in the sugar also diminished potency. Compounds were also evaluated in vitro against the parasites T. cruzi, T. brucei, and S. mansoni, revealing active compounds among this series.


Subject(s)
Cathepsin B/metabolism , Cysteine Endopeptidases/metabolism , Cysteine Proteinase Inhibitors/chemical synthesis , Protozoan Proteins/metabolism , Schistosoma mansoni/drug effects , Schistosoma mansoni/enzymology , Trypanocidal Agents/chemical synthesis , Animals , Cysteine Proteinase Inhibitors/chemistry , Cysteine Proteinase Inhibitors/pharmacology , Enzyme Activation/drug effects , Trypanocidal Agents/chemistry , Trypanocidal Agents/pharmacology
13.
Mem. Inst. Oswaldo Cruz ; 110(1): 65-74, 03/02/2015. tab, graf
Article in English | LILACS | ID: lil-741608

ABSTRACT

Aiming to identify new sources of bioactive secondary metabolites, we isolated 82 endophytic fungi from stems and barks of the native Brazilian tree Caesalpinia echinata Lam. (Fabaceae). We tested their ethyl acetate extracts in several in vitro assays. The organic extracts from three isolates showed antibacterial activity against Staphylococcus aureus and Escherichia coli [minimal inhibitory concentration (MIC) 32-64 μg/mL]. One isolate inhibited the growth of Salmonella typhimurium (MIC 64 μg/mL) and two isolates inhibited the growth of Klebsiella oxytoca (MIC 64 μg/mL), Candida albicans and Candida tropicalis (MIC 64-128 μg/mL). Fourteen extracts at a concentration of 20 μg/mL showed antitumour activities against human breast cancer and human renal cancer cells, while two isolates showed anti-tumour activities against human melanoma cancer cells. Six extracts were able to reduce the proliferation of human peripheral blood mononuclear cells, indicating some degree of selective toxicity. Four isolates were able to inhibit Leishmania (Leishmania) amazonensis and one isolate inhibited Trypanosoma cruzi by at least 40% at 20 μg/mL. The trypanocidal extract obtained from Fusarium sp. [KF611679] culture was subjected to bioguided fractionation, which revealed beauvericin as the compound responsible for the observed toxicity of Fusarium sp. to T. cruzi. This depsipeptide showed a half maximal inhibitory concentration of 1.9 μg/mL (2.43 μM) in a T. cruzi cellular culture assay.


Subject(s)
Animals , Humans , Anti-Bacterial Agents/isolation & purification , Food Preservatives/isolation & purification , Myrica/chemistry , Perciformes/microbiology , Plant Extracts/isolation & purification , Plant Leaves/chemistry , Seafood/microbiology , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/chemistry , China , Food Quality , Food Storage , Food Preservatives/adverse effects , Food Preservatives/chemistry , Foodborne Diseases/microbiology , Foodborne Diseases/prevention & control , Gram-Negative Bacteria/growth & development , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/growth & development , Gram-Positive Bacteria/isolation & purification , Hydrogen-Ion Concentration , Lipid Peroxidation , Microbial Sensitivity Tests , Pacific Ocean , Proteolysis , Plant Extracts/adverse effects , Plant Extracts/chemistry , Seafood/analysis
14.
Exp Parasitol ; 148: 73-80, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25450774

ABSTRACT

Cyclophilin (CyP), a peptidyl-prolyl cis/trans isomerase, is a key molecule with diverse biological functions that include roles in molecular chaperoning, stress response, immune modulation, and signal transduction. In this respect, CyP could serve as a potential drug target in disease-causing parasites. Previous studies employing proteomics techniques have shown that the TcCyP19 isoform was more abundant in a benznidazole (BZ)-resistant Trypanosoma cruzi population than in its susceptible counterpart. In this study, TcCyP19 has been characterized in BZ-susceptible and BZ-resistant T. cruzi populations. Phylogenetic analysis revealed a clear dichotomy between Cyphophilin A (CyPA) sequences from trypanosomatids and mammals. Sequencing analysis revealed that the amino acid sequences of TcCyP19 were identical among the T. cruzi samples analyzed. Southern blot analysis showed that TcCyP19 is a single-copy gene, located in chromosomal bands varying in size from 0.68 to 2.2 Mb, depending on the strain of T. cruzi. Northern blot and qPCR indicated that the levels of TcCyP19 mRNA were twofold higher in drug-resistant T. cruzi populations than in their drug-susceptible counterparts. Similarly, as determined by two-dimensional gel electrophoresis immunoblot, the expression of TcCyP19 protein was increased to the same degree in BZ-resistant T. cruzi populations. No differences in TcCyP19 mRNA and protein expression levels were observed between the susceptible and the naturally resistant T. cruzi strains analyzed. Taken together, these data indicate that cyclophilin TcCyP19 expression is up-regulated at both transcriptional and translational levels in T. cruzi populations that were in vitro-induced and in vivo-selected for resistance to BZ.


Subject(s)
Cyclophilins/genetics , Nitroimidazoles/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/genetics , Amino Acid Sequence , Chromosome Mapping , Cyclophilins/chemistry , Cyclophilins/classification , Cyclophilins/metabolism , DNA, Protozoan/analysis , DNA, Protozoan/chemistry , Drug Resistance , Gene Dosage , Gene Expression Regulation , Genome, Protozoan , Phylogeny , RNA, Messenger/metabolism , RNA, Protozoan/analysis , RNA, Protozoan/chemistry , Sequence Alignment , Sequence Analysis, DNA , Trypanosoma cruzi/chemistry , Trypanosoma cruzi/drug effects
15.
PLoS Negl Trop Dis ; 8(9): e3176, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25233456

ABSTRACT

BACKGROUND: Trypanosoma rangeli is a hemoflagellate protozoan parasite infecting humans and other wild and domestic mammals across Central and South America. It does not cause human disease, but it can be mistaken for the etiologic agent of Chagas disease, Trypanosoma cruzi. We have sequenced the T. rangeli genome to provide new tools for elucidating the distinct and intriguing biology of this species and the key pathways related to interaction with its arthropod and mammalian hosts. METHODOLOGY/PRINCIPAL FINDINGS: The T. rangeli haploid genome is ∼ 24 Mb in length, and is the smallest and least repetitive trypanosomatid genome sequenced thus far. This parasite genome has shorter subtelomeric sequences compared to those of T. cruzi and T. brucei; displays intraspecific karyotype variability and lacks minichromosomes. Of the predicted 7,613 protein coding sequences, functional annotations could be determined for 2,415, while 5,043 are hypothetical proteins, some with evidence of protein expression. 7,101 genes (93%) are shared with other trypanosomatids that infect humans. An ortholog of the dcl2 gene involved in the T. brucei RNAi pathway was found in T. rangeli, but the RNAi machinery is non-functional since the other genes in this pathway are pseudogenized. T. rangeli is highly susceptible to oxidative stress, a phenotype that may be explained by a smaller number of anti-oxidant defense enzymes and heat-shock proteins. CONCLUSIONS/SIGNIFICANCE: Phylogenetic comparison of nuclear and mitochondrial genes indicates that T. rangeli and T. cruzi are equidistant from T. brucei. In addition to revealing new aspects of trypanosome co-evolution within the vertebrate and invertebrate hosts, comparative genomic analysis with pathogenic trypanosomatids provides valuable new information that can be further explored with the aim of developing better diagnostic tools and/or therapeutic targets.


Subject(s)
Genome, Protozoan , Phylogeny , Trypanosoma rangeli/genetics , Animals , Base Sequence , DNA, Protozoan/genetics , Haploidy , Humans
16.
Mem. Inst. Oswaldo Cruz ; 109(3): 362-364, 06/2014. graf
Article in English | LILACS | ID: lil-711731

ABSTRACT

Four diamines and three amino alcohols derived from 1-decanol, 1-dodecanol and 1,2-dodecanediol were evaluated in an in vitro assay against a mixture of trypomastigote and intracellular amastigote forms of Trypanosoma cruzi. Two of these compounds (6 and 7) showed better activity against both proliferative stages of T. cruzi than the positive control benznidazole, three were of similar potency (1, 2 and 5) and two were less active (3 and 4).


Subject(s)
Amino Alcohols/pharmacology , Diamines/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Dose-Response Relationship, Drug , Parasitic Sensitivity Tests
17.
Mem Inst Oswaldo Cruz ; 109(3): 362-4, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24831550

ABSTRACT

Four diamines and three amino alcohols derived from 1-decanol, 1-dodecanol and 1,2-dodecanediol were evaluated in an in vitro assay against a mixture of trypomastigote and intracellular amastigote forms of Trypanosoma cruzi. Two of these compounds (6 and 7) showed better activity against both proliferative stages of T. cruzi than the positive control benznidazole, three were of similar potency (1, 2 and 5) and two were less active (3 and 4).


Subject(s)
Amino Alcohols/pharmacology , Diamines/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Dose-Response Relationship, Drug , Parasitic Sensitivity Tests
18.
Parasit Vectors ; 7: 197, 2014 Apr 24.
Article in English | MEDLINE | ID: mdl-24761813

ABSTRACT

BACKGROUND: Cysteine, a sulfur-containing amino acid, plays an important role in a variety of cellular functions such as protein biosynthesis, methylation, and polyamine and glutathione syntheses. In trypanosomatids, glutathione is conjugated with spermidine to form the specific antioxidant thiol trypanothione (T[SH]2) that plays a central role in maintaining intracellular redox homeostasis and providing defence against oxidative stress. METHODS: We cloned and characterised genes coding for a cystathionine ß-synthase (CßS) and cysteine synthase (CS), key enzymes of the transsulfuration and assimilatory pathways, respectively, from the hemoflagellate protozoan parasite Trypanosoma rangeli. RESULTS: Our results show that T. rangeli CßS (TrCßS), similar to its homologs in T. cruzi, contains the catalytic domain essential for enzymatic activity. Unlike the enzymes in bacteria, plants, and other parasites, T. rangeli CS lacks two of the four lysine residues (Lys26 and Lys184) required for activity. Enzymatic studies using T. rangeli extracts confirmed the absence of CS activity but confirmed the expression of an active CßS. Moreover, CßS biochemical assays revealed that the T. rangeli CßS enzyme also has serine sulfhydrylase activity. CONCLUSION: These findings demonstrate that the RTS pathway is active in T. rangeli, suggesting that this may be the only pathway for cysteine biosynthesis in this parasite. In this sense, the RTS pathway appears to have an important functional role during the insect stage of the life cycle of this protozoan parasite.


Subject(s)
Cysteine/biosynthesis , Trypanosoma rangeli/enzymology , Amino Acid Sequence , Animals , Cloning, Molecular , Cystathionine beta-Synthase/genetics , Cystathionine beta-Synthase/metabolism , Cysteine Synthase/genetics , Cysteine Synthase/metabolism , Gene Expression Regulation, Enzymologic , Molecular Sequence Data , Oxidative Stress , Phosphatidylethanolamines , Species Specificity , Trypanosoma cruzi/enzymology
19.
J Antimicrob Chemother ; 69(1): 150-4, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23970484

ABSTRACT

OBJECTIVES: To evaluate in vitro interactions between paromomycin sulphate and the antileishmanial drugs meglumine antimoniate, amphotericin B, miltefosine and azithromycin against intracellular Leishmania (Leishmania) infantum chagasi, Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis amastigotes in peritoneal mouse macrophages. METHODS: First, drug susceptibility was assessed in 3, 5 and 7 day assays, followed by drug interaction assays with a modified fixed-ratio method. An overall mean sum fractional inhibitory concentration (∑FIC) was calculated for each combination and each Leishmania species. The nature of the interactions was classified as synergistic if the mean ∑FIC was ≤ 0.5, indifferent if the mean ∑FIC was >0.5-4.0 and antagonistic if the mean ∑FIC was >4.0. RESULTS: In vitro synergism was observed for the combinations of paromomycin plus miltefosine [at 50% and 90% inhibitory concentrations (IC50 and IC90, respectively)] and paromomycin plus amphotericin B (at the IC90 level) against L. (L.) amazonensis, paromomycin plus meglumine antimoniate (at the IC50 and IC90 levels) and paromomycin plus amphotericin B (at the IC50 level) against L. (V.) braziliensis, and paromomycin plus miltefosine, paromomycin plus amphotericin B (both at the IC90 level) and paromomycin plus azithromycin (at the IC50 level) against L. (L) infantum chagasi. CONCLUSIONS: This work provides a preclinical dataset that supports future studies on multidrug treatment schedules against New World leishmaniasis.


Subject(s)
Antiprotozoal Agents/pharmacology , Drug Synergism , Leishmania braziliensis/drug effects , Leishmania infantum/drug effects , Leishmania mexicana/drug effects , Paromomycin/pharmacology , Animals , Cells, Cultured , Inhibitory Concentration 50 , Macrophages/parasitology , Mice , Parasitic Sensitivity Tests
20.
Mem Inst Oswaldo Cruz ; 107(4): 494-502, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22666860

ABSTRACT

Ascorbate peroxidases (APX) are class I heme-containing enzymes that convert hydrogen peroxide into water molecules. The gene encoding APX has been characterized in 11 strains of Trypanosoma cruzi that are sensitive or resistant to benznidazole (BZ). Bioinformatic analysis revealed the presence of two complete copies of the T. cruzi APX (TcAPX) gene in the genome of the parasite, while karyotype analysis showed that the gene was present in the 2.000-kb chromosome of all of the strains analyzed. The sequence of TcAPX exhibited greater levels of similarity to those of orthologous enzymes from Leishmania spp than to APXs from the higher plant Arabidopsis thaliana. Northern blot and real-time reverse transcriptase polymerase chain reaction (RT-PCR) analyses revealed no significant differences in TcAPX mRNA levels between the T. cruzi strains analyzed. On the other hand, Western blots showed that the expression levels of TcAPX protein were, respectively, two and three-fold higher in T. cruzi populations with in vitro induced (17 LER) and in vivo selected (BZR) resistance to BZ, in comparison with their corresponding susceptible counterparts. Moreover, the two BZ-resistant populations exhibited higher tolerances to exogenous hydrogen peroxide than their susceptible counterparts and showed TcAPX levels that increased in a dose-dependent manner following exposure to 100 and 200 µM hydrogen peroxide.


Subject(s)
Ascorbate Peroxidases/analysis , Drug Resistance/genetics , Hydrogen Peroxide/pharmacology , Nitroimidazoles/pharmacology , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/enzymology , Ascorbate Peroxidases/genetics , Blotting, Western , DNA, Protozoan/analysis , Electrophoresis, Gel, Pulsed-Field , Molecular Sequence Data , Phylogeny , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA , Trypanosoma cruzi/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...